What is China Medical & HealthCare Group EV-to-EBITDA?
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, China Medical & HealthCare Group's enterprise value is HK$640 Mil.
China Medical & HealthCare Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$83 Mil. Therefore, China Medical & HealthCare Group's EV-to-EBITDA for today is 7.69.
The historical rank and industry rank for China Medical & HealthCare Group's EV-to-EBITDA or its related term are showing as below:
HKSE:00383'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.34 Med: 21.81 Max: 91.15
Current: 7.69
During the past 13 years, the highest EV-to-EBITDA of China Medical & HealthCare Group was 91.15. The lowest was -15.34. And the median was 21.81.
HKSE:00383's EV-to-EBITDA is ranked better than 75.65% of 460
companies
in the Healthcare Providers & Services industry
Industry Median: 13.18
vs HKSE:00383: 7.69
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Medical & HealthCare Group EV-to-EBITDA Chart
Competitive Comparison of China Medical & HealthCare Group's EV-to-EBITDA
For the Medical Care Facilities subindustry, China Medical & HealthCare Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Medical & HealthCare Group's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Medical & HealthCare Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where China Medical & HealthCare Group's EV-to-EBITDA falls into.
China Medical & HealthCare Group EV-to-EBITDA Calculation
China Medical & HealthCare Group's current Enterprise Value is HK$640 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical & HealthCare Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Medical & HealthCare Group (HKSE:00383) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
China Medical & HealthCare Group's PE Ratio for today is calculated as:
China Medical & HealthCare Group's share price for today is HK$0.68.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical & HealthCare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
China Medical & HealthCare Group EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of China Medical & HealthCare Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
China Medical & HealthCare Group (HKSE:00383) Business Description
China Medical & HealthCare Group Ltd is a healthcare company operating hospitals. Its main focus is on the investment, management, and operations of healthcare and hospital businesses, eldercare businesses, trading of medical equipment and related supplies, property investment and development, securities trading and investments, provision of financial services, and strategic investment. It operates through the following business segments: Healthcare, Eldercare; Property development; Property investment; Financial services; and Securities trading and investments. The firm generates the majority of revenue from the Healthcare segment that is engaged in the operations of hospitals in the PRC.
China Medical & HealthCare Group (HKSE:00383) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00383 has been successfully added to your 